臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

	English \| 正體中文 \| 简体中文 \| 總筆數 :2856796
	造訪人次 : 53886032 線上人數 : 1225 教育部委託研究計畫計畫執行:國立臺灣大學圖書館

搜尋範圍

進階搜尋

登入

管理

臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"szu chun"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 16-25 / 30 (共3頁)
<< < 1 2 3 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
國立成功大學	2022-02-28	The impact of driver mutation on the treatment outcome of early-stage lung cancer patients receiving neoadjuvant immunotherapy and chemotherapy	Su;Po-Lan;Chen;Jung-Yueh;Chu;Chang-Yao;Chen;Yi-Lin;Chen;Wan-Li;Lin;Kuan-Yu;Ho;Chung-Liang;Tsai;Jeng-Shiuan;Yang;Szu-Chun;Chen;Chian-Wei;Wu;Yi-Lin;Tseng;Yau-Lin;Chang;Chao-Chun;Yen;Yi-Ting;Lin;Chia-Ying;Lin;Chien-Chung;Su;Wu-Chou
國立成功大學	2022-01	Improved survival in patients with unresectable stage III EGFR-mutant adenocarcinoma with upfront EGFR-tyrosine kinase inhibitors	Wang;Sheng-Yuan;Lai;Ching-Han;Chen;Chian-Wei;Yang;Szu-Chun;Chang;Chao-Chun;Lin;Chia-Ying;Yen;Yi-Ting;Tseng;Yau-Lin;Su;Po-Lan;Lin;Chien-Chung;Su;Wu-Chou
國立成功大學	2021-12	QALYs and medical costs saved from prevention of a cancer: Analysis of nation-wide real-world data of Taiwan with lifetime horizon	Lai;Wu-Wei;Chung;Chia-Hua;Lin;Chia-Ni;Yang;Szu-Chun;Hwang;Jing-Shiang;Wang;Jung-Der
國立成功大學	2021-09	EGFR-TKI plus bevacizumab versus EGFR-TKI monotherapy for patients with EGFR mutation-positive advanced non-small cell lung cancer-A propensity score matching analysis	Tsai;Jeng-Shiuan;Su;Po-Lan;Yang;Szu-Chun;Chang;Chao-Chun;Lin;Chia-Ying;Yen;Yi-Ting;Tseng;Yau-Lin;Lai;Wu-Wei;Lin;Chien-Chung;Su;Wu-Chou
國立成功大學	2021-06-9	Considering lead-time bias in evaluating the effectiveness of lung cancer screening with real-world data	Yang;Szu-Chun;Wang;Jung-Der;Wang;Shi-Yi
國立成功大學	2021-04	Downstream Complications and Healthcare Expenditure after Invasive Procedures for Lung Lesions in Taiwan	Yang;Szu-Chun;Lai;Ching-Han;Kuo;Chin-Wei;Lin;Chien-Chung;Lai;Wu-Wei;Wang;Jung-Der
國立成功大學	2020-12	Indigenous recurrent disseminated histoplasmosis in Taiwan	Kuo;Hung-I;Liao;Xin-Min;Yang;Szu-Chun;Lee;Jen-Chieh;Chang;Kung-Chao;Cia;Cong-Tat
國立成功大學	2020-04-8	Comparative effectiveness and cost-effectiveness of three first-line EGFR-tyrosine kinase inhibitors: Analysis of real-world data in a tertiary hospital in Taiwan	Yang;Szu-Chun;Lai;Wu-Wei;Hsu;Jason, C.;Su;Wu-Chou;Wang;Jung-Der
國立成功大學	2019-11	Dynamic Changes of Health Utility in Lung Cancer Patients Receiving Different Treatments: A 7-Year Follow-up	Yang;Szu-Chun;Kuo;Chin-Wei;Lai;Wu-Wei;Lin;Chien-Chung;Su;Wu-Chou;Chang;Sheng-Mao;Wang;Jung-Der
國立成功大學	2019-10	Real-world outcomes of NSCLC patients receiving tissue or circulating tumor DNA-guided osimertinib treatment	Su;Po-Lan;Yang;Szu-Chun;Chen;Yi-Lin;Wu;Yi-Lin;Lin;Chia-Ying;Chang;Wei-Yuan;Tseng;Yau-Lin;Lai;Wu-Wei;Ho;Chung-Liang;Lin;Chien-Chung;Su;Wu-Chou

顯示項目 16-25 / 30 (共3頁)
<< < 1 2 3 > >>
每頁顯示[10|25|50]項目